International Assets Investment Management LLC Has $7.84 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

International Assets Investment Management LLC grew its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 39,466.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 26,114 shares of the medical instruments supplier’s stock after buying an additional 26,048 shares during the period. International Assets Investment Management LLC’s holdings in West Pharmaceutical Services were worth $7,838,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Monte Financial Group LLC increased its stake in shares of West Pharmaceutical Services by 92.2% in the 3rd quarter. Monte Financial Group LLC now owns 3,925 shares of the medical instruments supplier’s stock valued at $1,178,000 after buying an additional 1,883 shares during the period. Fulcrum Capital LLC increased its stake in shares of West Pharmaceutical Services by 2.0% in the 3rd quarter. Fulcrum Capital LLC now owns 8,124 shares of the medical instruments supplier’s stock valued at $2,438,000 after buying an additional 162 shares during the period. Elevated Capital Advisors LLC increased its stake in shares of West Pharmaceutical Services by 8.8% in the 3rd quarter. Elevated Capital Advisors LLC now owns 1,301 shares of the medical instruments supplier’s stock valued at $391,000 after buying an additional 105 shares during the period. Global X Japan Co. Ltd. increased its stake in shares of West Pharmaceutical Services by 19.9% in the 3rd quarter. Global X Japan Co. Ltd. now owns 1,303 shares of the medical instruments supplier’s stock valued at $391,000 after buying an additional 216 shares during the period. Finally, Eastern Bank acquired a new stake in shares of West Pharmaceutical Services during the third quarter worth $82,000. 93.90% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the business’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total value of $218,211.20. Following the completion of the transaction, the vice president now directly owns 1,253 shares of the company’s stock, valued at approximately $388,931.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Stock Down 1.6 %

Shares of West Pharmaceutical Services stock opened at $307.90 on Friday. The company has a quick ratio of 2.23, a current ratio of 3.00 and a debt-to-equity ratio of 0.07. West Pharmaceutical Services, Inc. has a 12 month low of $265.00 and a 12 month high of $413.70. The business has a fifty day simple moving average of $301.40 and a 200 day simple moving average of $320.19. The stock has a market cap of $22.30 billion, a PE ratio of 45.68, a price-to-earnings-growth ratio of 23.68 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.50 by $0.35. West Pharmaceutical Services had a return on equity of 18.41% and a net margin of 17.37%. The business had revenue of $746.90 million during the quarter, compared to analysts’ expectations of $709.62 million. During the same period in the previous year, the firm earned $2.16 earnings per share. The firm’s quarterly revenue was down .1% compared to the same quarter last year. Research analysts predict that West Pharmaceutical Services, Inc. will post 6.55 EPS for the current year.

West Pharmaceutical Services Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be paid a dividend of $0.21 per share. The ex-dividend date is Wednesday, November 13th. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.27%. West Pharmaceutical Services’s payout ratio is 12.46%.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.